These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 29252093

  • 21. Association of dihydrofolate reductase (DHFR) -317AA genotype with poor response to methotrexate in patients with rheumatoid arthritis.
    Milic V, Jekic B, Lukovic L, Bunjevacki V, Milasin J, Novakovic I, Damnjanovic T, Popovic B, Maksimovic N, Damjanov N, Radunovic G, Pejnovic N, Krajinovic M.
    Clin Exp Rheumatol; 2012; 30(2):178-83. PubMed ID: 22324981
    [Abstract] [Full Text] [Related]

  • 22. Methotrexate treatment in rheumatoid arthritis and elevated liver enzymes: A long-term follow-up of predictors, surveillance, and outcome in clinical practice.
    Karlsson Sundbaum J, Eriksson N, Hallberg P, Lehto N, Wadelius M, Baecklund E.
    Int J Rheum Dis; 2019 Jul; 22(7):1226-1232. PubMed ID: 31012257
    [Abstract] [Full Text] [Related]

  • 23. The C677T mutation in the methylenetetrahydrofolate reductase gene: a genetic risk factor for methotrexate-related elevation of liver enzymes in rheumatoid arthritis patients.
    van Ede AE, Laan RF, Blom HJ, Huizinga TW, Haagsma CJ, Giesendorf BA, de Boo TM, van de Putte LB.
    Arthritis Rheum; 2001 Nov; 44(11):2525-30. PubMed ID: 11710708
    [Abstract] [Full Text] [Related]

  • 24. Polymorphisms and pharmacogenomics for the toxicity of methotrexate monotherapy in patients with rheumatoid arthritis: A systematic review and meta-analysis.
    Qiu Q, Huang J, Lin Y, Shu X, Fan H, Tu Z, Zhou Y, Xiao C.
    Medicine (Baltimore); 2017 Mar; 96(11):e6337. PubMed ID: 28296761
    [Abstract] [Full Text] [Related]

  • 25. Initial methotrexate dosage is not associated with an increased risk of liver toxicity in patients with rheumatoid arthritis.
    Choi SR, Park JW, Lee EB, Park JK.
    Clin Rheumatol; 2021 Nov; 40(11):4493-4500. PubMed ID: 34115231
    [Abstract] [Full Text] [Related]

  • 26. Adverse events and factors associated with toxicity in patients with early rheumatoid arthritis treated with methotrexate tight control therapy: the CAMERA study.
    Verstappen SM, Bakker MF, Heurkens AH, van der Veen MJ, Kruize AA, Geurts MA, Bijlsma JW, Jacobs JW, Utrecht Rheumatoid Arthritis Cohort Study Group.
    Ann Rheum Dis; 2010 Jun; 69(6):1044-8. PubMed ID: 19581281
    [Abstract] [Full Text] [Related]

  • 27. Genome-wide association study of liver enzyme elevation in rheumatoid arthritis patients starting methotrexate.
    Sundbaum JK, Baecklund E, Eriksson N, Kohnke H, Wallenberg M, Cavalli M, Wadelius C, Wadelius M, Hallberg P.
    Pharmacogenomics; 2021 Oct; 22(15):973-982. PubMed ID: 34521259
    [Abstract] [Full Text] [Related]

  • 28. Genetic Determinants of Methotrexate Toxicity in Tunisian Patients with Rheumatoid Arthritis: A Study of Polymorphisms Involved in the MTX Metabolic Pathway.
    Chaabane S, Marzouk S, Akrout R, Ben Hamad M, Achour Y, Rebai A, Keskes L, Fourati H, Bahloul Z, Maalej A.
    Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):385-93. PubMed ID: 26077125
    [Abstract] [Full Text] [Related]

  • 29. Methotrexate use in rheumatoid arthritis is associated with few clinically significant liver function test abnormalities.
    Yazici Y, Erkan D, Harrison MJ, Nikolov NP, Paget SA.
    Clin Exp Rheumatol; 2005 Aug; 23(4):517-20. PubMed ID: 16095122
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Methotrexate, liver and rheumatoid arthritis in tropical areas].
    Diouf ML, Diallo S, Mbengue M, Moreira-Diop T.
    Sante; 2001 Aug; 11(3):195-200. PubMed ID: 11641084
    [Abstract] [Full Text] [Related]

  • 32. Liver Fibrosis in Rheumatoid Arthritis Patients Treated with Methotrexate.
    Hilal G, Akasbi N, Boudouaya H, Salma K, Harzy T.
    Curr Rheumatol Rev; 2020 Aug; 16(4):293-297. PubMed ID: 32189595
    [Abstract] [Full Text] [Related]

  • 33. Effectiveness, tolerability, and safety of subcutaneous methotrexate in early rheumatoid arthritis: A retrospective analysis of real-world data from the St. Gallen cohort.
    Müller RB, von Kempis J, Haile SR, Schiff MH.
    Semin Arthritis Rheum; 2015 Aug; 45(1):28-34. PubMed ID: 25895697
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. A meta-analysis of the association between the ATIC 347 C/G polymorphism and methotrexate responsiveness and toxicity in rheumatoid arthritis.
    Lee YH, Song GG.
    Semin Arthritis Rheum; 2024 Feb; 64():152337. PubMed ID: 38071832
    [Abstract] [Full Text] [Related]

  • 36. Methotrexate-related toxicity in patients with rheumatoid arthritis and renal dysfunction.
    Lee JS, Oh JS, Kim YG, Lee CK, Yoo B, Hong S.
    Rheumatol Int; 2020 May; 40(5):765-770. PubMed ID: 32170389
    [Abstract] [Full Text] [Related]

  • 37. Efficacy of leflunomide 100mg weekly compared to low dose methotrexate in patients with active rheumatoid arthritis. Double blind, randomized clinical trial.
    Jaimes-Hernández J, Meléndez-Mercado CI, Mendoza-Fuentes A, Aranda-Pereira P, Castañeda-Hernández G.
    Reumatol Clin; 2012 May; 8(5):243-9. PubMed ID: 22763150
    [Abstract] [Full Text] [Related]

  • 38. Role of key TYMS polymorphisms on methotrexate therapeutic outcome in portuguese rheumatoid arthritis patients.
    Lima A, Seabra V, Bernardes M, Azevedo R, Sousa H, Medeiros R.
    PLoS One; 2014 May; 9(10):e108165. PubMed ID: 25279663
    [Abstract] [Full Text] [Related]

  • 39. Risk factors for methotrexate-induced abnormal laboratory monitoring results in patients with rheumatoid arthritis.
    Kent PD, Luthra HS, Michet C.
    J Rheumatol; 2004 Sep; 31(9):1727-31. PubMed ID: 15338491
    [Abstract] [Full Text] [Related]

  • 40. Impact of genetic variants of ATP binding cassette B1, AICAR transformylase/IMP cyclohydrolase, folyl-polyglutamatesynthetase, and methylenetetrahydrofolatereductase on methotrexate toxicity.
    Sala-Icardo L, Lamana A, Ortiz AM, García Lorenzo E, Moreno Fresneda P, García-Vicuña R, González-Álvaro I.
    Reumatol Clin; 2017 Sep; 13(6):318-325. PubMed ID: 27751863
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.